PP
Piramal Pharma Ltd (Piramal Pharma Solutions)
CDMO · Navi Mumbai, India
GMP
Overview
Piramal Pharma Solutions is the CDMO business of Piramal Pharma Ltd, with sites in North America, Europe and Asia. Its Turbhe facility in Navi Mumbai handles peptide process development and commercial manufacturing using solid- and solution-phase synthesis and offers generic peptide APIs from multigram to kilogram scale. Piramal Pharma holds active US Type II DMFs for Cetrorelix, Desmopressin, Lanreotide, Leuprolide, Liraglutide, Octreotide, Oxytocin, Semaglutide, Vasopressin. The company says the site is accredited by USFDA, EDQM, AIFA and KFDA, and FDA issued a Form 483 after a February 2025 inspection of the Navi Mumbai API plant.
Capabilities
- Peptide CDMO
- Solid- and solution-phase synthesis
- Generic peptide APIs
- Long-chain peptides
- Freeze drying
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |